Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

NCT07583251 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment (MCI)

Interventions

DRUG: Gamma- Glutamylcysteine
DRUG: Gamma- Glutamylcysteine
DRUG: Gamma- Glutamylcusteine

Sponsor

Pravat Mandal

Collaborators

[object Object]
[object Object]